[{"address1": "3 Temasek Avenue", "address2": "Level 18 Centennial Tower", "city": "Singapore", "zip": "039190", "country": "Singapore", "phone": "65 6817 9598", "website": "https://aslanpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal antibody that targets the IL-13 receptor a1 subunit which is being developed for the treatment of atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune diseases. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl Alan Jason Morton Firth EMBA, Ph.D.", "age": 50, "title": "Founder, CEO & Executive Director", "yearBorn": 1973, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kiran Kumar  Asarpota", "age": 44, "title": "COO & Head of Finance", "yearBorn": 1979, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ben  Goodger", "age": 60, "title": "General Counsel", "yearBorn": 1963, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Doyle", "age": 50, "title": "Chief Business Officer", "yearBorn": 1973, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alexandre  Kaoukhov M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Charlie  Hsu", "title": "Investor Relations Director", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Chi-Chin  Wang", "title": "IR & Corporate Development Director", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.491, "open": 0.491, "dayLow": 0.491, "dayHigh": 0.58, "regularMarketPreviousClose": 0.491, "regularMarketOpen": 0.491, "regularMarketDayLow": 0.491, "regularMarketDayHigh": 0.58, "forwardPE": -0.2231405, "volume": 303655, "regularMarketVolume": 303655, "averageVolume": 1002880, "averageVolume10days": 160260, "averageDailyVolume10Day": 160260, "marketCap": 12218472, "fiftyTwoWeekLow": 0.392, "fiftyTwoWeekHigh": 4.69, "priceToSalesTrailing12Months": 1.018206, "fiftyDayAverage": 0.61026, "twoHundredDayAverage": 1.22983, "currency": "USD", "enterpriseValue": 238894240, "floatShares": 371909632, "sharesOutstanding": 22626800, "sharesShort": 116785, "sharesShortPriorMonth": 19330, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0052, "heldPercentInsiders": 0.00054000004, "heldPercentInstitutions": 0.15486, "shortRatio": 0.05, "shortPercentOfFloat": 0.0052, "impliedSharesOutstanding": 24382000, "bookValue": -0.769, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -44219604, "trailingEps": -2.75, "forwardEps": -2.42, "lastSplitFactor": "1:5", "lastSplitDate": 1678665600, "enterpriseToRevenue": 19.908, "enterpriseToEbitda": -5.506, "52WeekChange": -0.8643216, "SandP52WeekChange": 0.21231294, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ASLN", "underlyingSymbol": "ASLN", "shortName": "ASLAN Pharmaceuticals Limited", "longName": "ASLAN Pharmaceuticals Limited", "firstTradeDateEpochUtc": 1525440600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "64d5d950-3f7f-30f1-9c3d-4a28bad97a03", "messageBoardId": "finmb_419159771", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.54, "targetHighPrice": 10.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.5, "targetMedianPrice": 9.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 21252058, "totalCashPerShare": 0.049, "ebitda": -43387100, "totalDebt": 26825126, "quickRatio": 1.62, "currentRatio": 1.84, "totalRevenue": 12000000, "revenuePerShare": 0.746, "returnOnAssets": -0.63708, "freeCashflow": -32717308, "operatingCashflow": -46639000, "grossMargins": 1.0, "operatingMargins": -3.6446302, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-19"}]